Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-8 of 8 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Low-grade UTUC Treated With Nadofaragene Firadenovec Administered To Renal Pelvis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Testing The Role Of DNA Released From Tumor Cells Into The Blood In Guiding The Use Of Immunotherapy After Surgical Removal Of The Bladder, Kidney, Ureter, And Urethra For Urothelial Cancer Treatment, MODERN Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Enfortumab Vedotin And Pembrolizumab With Cystectomy And/or Ureterectomy For Locally Advanced Or Metastatic Bladder And Upper Urothelial Tract Cancer, CAST-AI Trial

    Rochester, MN

  4. Study Of Datopotamab Deruxtecan Plus Carboplatin Or Cisplatin Versus Gemcitabine Plus Carboplatin Or Cisplatin In Participants With Locally Advanced Or Metastatic Urothelial Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Study Of Zanzalintinib In Combination With Immuno-Oncology Agents In Participants With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Mapping Patient-Centered Decision-Making In Metastatic Cancer Care Delivery In Florida

    Jacksonville, FL

  7. Ultrasound-Guided Core Needle Biopsy To Stage Urothelial Carcinoma Of The Bladder (US UCB)

    Rochester, MN

  8. Surgical Drain Fluid For Detection Of Molecular Residual Disease (MRD) In Bladder, Renal And Urothelial Cancers

    Rochester, MN

.

Mayo Clinic Footer